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A comprehensive longitudinal understanding of the changing epidemiology of the agents
causing bacteraemia and their AMR profiles in key locations is crucial for assessing
the progression and magnitude of the global AMR crisis. We performed a retrospective
analysis of routine microbiological data from April 1992 to December 2014, studying the
time trends of non-Salmonella associated bacteraemia at a single Kathmandu healthcare
facility. The distribution of aetiological agents, their antimicrobial susceptibility profiles,
and the hospital ward of isolation were assessed. Two hundred twenty-four thousand
seven hundred forty-one blood cultures were performed over the study period, of
which, 30,353 (13.5%) exhibited growth for non-contaminant bacteria. We observed a
significant increasing trend in the proportion of MDR non-Salmonella Enterobacteriaceae
(p < 0.001), other Gram-negative organisms (p = 0.006), and Gram-positive organisms
(p= 0.006) over time. Additionally, there was an annual increasing trend in the proportion
of MDR organisms in bacteria-positive blood cultures originating from patients attending
the emergency ward (p = 0.006) and the outpatient department (p = 0.006). This
unique dataset demonstrates that community acquired non-Salmonella bacteraemia
has become an increasingly important cause of hospital admission in Kathmandu. An
increasing burden of bacteraemia associated with MDR organisms in the community
underscores the need for preventing the circulation of MDR bacteria within the local
population.
Keywords: bloodstream infections, bacteraemia, blood culture, surveillance, community acquired, antimicrobial
resistance, enterobacteriaceae, Nepal
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INTRODUCTION
Bacteraemia continues to be a common cause of febrile illness
worldwide, and is associated with substantial morbidity and
mortality (1, 2). The spectrum of organisms causing bacteraemia
is variable and highly setting-specific (2–4). The disease severity
and outcome of bacteraemia can also vary significantly, and are
related to multiple factors, including the genetic composition of
the infecting bacteria, susceptibility of the host, and the clinical
management of the patient (5–7).
In recent years, there have been substantial changes in
the aetiological agents of bacteraemia and their associated
antimicrobial susceptibility profiles (5, 6, 8). The rapid
administration of an effective antimicrobial is imperative for
the clinical management of bacteraemia; however increasing
antimicrobial resistance (AMR) restricts treatment options. The
sustained usage of broad-spectrum antimicrobials has become
associated with the emergence, selection, and circulation of
invasive bacterial pathogens exhibiting AMR tomany empirically
prescribed antimicrobials (9). Therefore, a comprehensive
longitudinal understanding of the changing epidemiology of the
agents causing bacteraemia and their AMR profiles in specific
locations is crucial for assessing the scale of the global AMR
crisis, revising rational management strategies, and improving
treatment guidelines (10, 11).
In Nepal, febrile disease is a common reason for seeking
medical attention (12). Like in many other low-income
countries, much of the febrile disease burden in Nepal
is associated with community-acquired infections. Invasive
Salmonella serovars Typhi and Paratyphi A, now with resistance
against fluoroquinolones, remain the organisms most frequently
isolated from the blood of febrile patients in the Kathmandu
Valley (12–14). However, invasive Salmonella are less adept
at acquiring resistance to multiple antimicrobials than other
indicator organisms and may not reflect general trends in AMR
(15). Furthermore, Salmonella Typhi and Paratyphi A are well
established and well described pathogens in the Kathmandu
Valley, but little has been reported for non-Salmonella associated
bacteraemia. To investigate the epidemiology and AMR profile
of agents causing bacteraemia in this setting, we performed a
retrospective analysis on 23 years of data regarding the etiology of
non-Salmonella associated bacteraemia at Patan hospital, a major
general hospital in the Kathmandu Valley.
METHODS
Ethics Statement
This study used anonymised data, originating from the
microbiology laboratory of Patan Hospital in Kathmandu,
consisting of culture result, isolated organism, ward in which the
blood sample was taken, and associated AMR profile. This study
was, therefore, a component of the routine surveillance measures
for infection control at Patan Hospital and local ethical approval
and individual written informed consent were not required.
However, a written permission, for access and analysis of the data,
was sought and obtained from the Hospital.
Study Design
This study was a retrospective analysis of routine microbiology
laboratory results of all blood cultures taken at Patan Hospital
between April 1992 and December 2014. It is one of three
general hospitals in the greater metropolitan area of Kathmandu.
The hospital had a capacity of 138 beds in 1992, 350 beds in
2014, a current capacity of 592 beds, and provides emergency
and elective services to outpatients (∼200,000 outpatient visits
per year) and inpatients, 90% of which live in Lalitpur Sub
Metropolitan City LSMC.
Systematic criteria concerning which patients had a blood
culture performed were not used during the course of the study.
However, a blood culture was generally performed on patients in
whom a bacterial infection was suspected on the basis of a fever
(>38◦C) or evidence of sepsis on the basis of the presence of two
or more of the following criteria: fever (>38◦C) or sub-normal
temperature (<36◦C), tachycardia, tachypnoea, elevated white
cell count (>12,000 cells/mm3), or depressed white cell count
(<4,000 cells/mm3). Review of the microbiological standard
operating procedures over the analysis time period suggest
no substantive changes in the application of these criteria.
Bacteraemia was defined as isolation of at least one clinically
relevant pathogen from one blood culture drawn from a patient
with an indicative clinical syndrome. Organisms of the same
species with the same antimicrobial susceptibility profile isolated
from the same patient (matching hospital ID number) were
removed from analysis.
Microbiology Procedures and
Antimicrobial Susceptibility Testing
The majority of blood cultures were performed manually
by inoculating 3–5mL (pediatric patients) or 5–8mL (adult
patients) of blood into 30–50mL of media containing tryptone
soya broth and 0.05% sodium polyanetholesulfonate. An
automated BACTEC (Becton Dickinson, MD, USA) system
was introduced for cultures on blood taken from those aged
<14 years from 2005 onwards. Blood samples from children
were inoculated into BACTEC Peds plus bottles following
the manufacturers recommendations (Becton Dickinson, MD,
USA). All inoculated blood bottles were incubated at 37◦C and
examined daily over 7 days for bacterial growth, or until flagged
in the automated system. For all conventional bottles, irrespective
of whether turbidity developed or not, the inoculated broth
was sub-cultured and Gram stained on sixth day of incubation.
Organisms isolated from the primary cultures were sub-cultured
onto sheep blood agar and chocolate agar. Plates were incubated
at 37◦C for 48 h. Organisms were identified by standard methods
including API20E identification kits (Bio-Mérieux, Craponne,
France) and specific antisera where possible. Coagulase negative
staphylococci were reported only for neonates as pathogens and
as contaminants for the rest of the population. Gram-negative
rods that were not identifiable through biochemical tests were
reported as Gram-negative rods.
Antimicrobial susceptibility testing was performed at time of
isolation by the modified Kirby-Bauer disc diffusion method.
Zone size interpretations were initially performed following the
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guidelines provided in the antimicrobial disc packaging; from
2003 onwards, susceptibilities were inferred by following the
appropriate CLSI guidelines. A range of antimicrobials were
tested, this was largely dependent on the period of isolation
(Table S1).
Statistical Analysis
For analysis purposes, resistant and intermediate organisms were
grouped as “non-susceptible.” Multi-drug resistance (MDR) was
defined as “acquired non-susceptibility to at least one agent in
three or more antimicrobial categories” (16). The categories used
in this study are described in Table S2. As current practice,
laboratory results reporting resistance to an antimicrobial for
which an organism was intrinsically resistant were not taken into
account when generating the MDR profile. Intrinsic resistance
were determined according to the 2014 Clinical and Laboratory
Standards Institute (CLSI) guidelines (Table S3) (17). Increasing
or decreasing trends in isolated organisms and AMR profiles
were measured using Cox and Stuart test for trends (R-package
“randtrends”). Davies’ test (R-package “segmented”) was used to
detect a non-constant regression parameter (i.e., change in slope)
when the percentage of MDRwas regressed on years. All analyses
were performed using the statistical software R version 3.3.2 (18).
RESULTS
General Observations
From April 1992 to December 2014, a total of 224,741 blood
cultures were performed at Patan Hospital, of which 173,892
(77.4%) were culture negative, and a further 20,410 (9.1%)
contained a contaminant organism. A non-contaminant fungal
pathogen was identified in 86 blood samples, the remaining
30,353 (13.5%) blood cultures exhibited growth for non-
contaminant bacteria (Table 1). The most frequently isolated
organisms were Salmonella Typhi and Salmonella Paratyphi A,
associated with 44.8% (13,592/30,353) and 20.0% (6,057/30,353)
of all bacteria-positive blood cultures, respectively (Table S4).
The most frequently isolated non-Salmonella organisms were
(in decreasing frequency) Enterobacter spp., Acinetobacter
spp., Coagulase negative Staphylococci, Escherichia coli,
TABLE 1 | Summary of the blood cultures performed between April 1992 and
December 2014.
Blood cultures (n = 224,741) N Proportion of cultures (%)
Culture negative 173,892 77.37
Contamination* 20,410 9.08
Fungi 86 0.04
Culture bacteriologically positive 30,353 13.51
Salmonella enterica 19,857 8.84
Enterobacteriaceae non-Salmonella 4,029 1.79
Gram-negative (other) 2,087 0.93
Gram-positive 4,380 1.95
*Organisms that were classified as contaminants included Bacillus spp., Micrococcus
spp., Coagulase negative staphylococci excluding those from neonates and diptheroids.
Klebsiella spp. (including both K. pneumoniae and K. oxytoca),
Staphylococcus aureus, Non-haemolytic Streptococci, and
Streptococcus pneumoniae (Table S4). Between 1992 and 2014,
the total number of blood cultures performed increased, but the
proportion of blood samples exhibiting bacterial growth showed
a decreasing trend (p < 0.001; Cox and Stuart test) (Figure S1).
Time Trends of Gram-Positive and
Gram-Negative Bacteria
The annual distribution of the aetiological agents associated with
bacteraemia, stratified by non-Salmonella Enterobacteriaceae,
other Gram-negative organisms, and Gram-positive organisms
(19), is shown in Figure 1. The absolute annual counts of
Enterobacteriaceae and Gram-positive organisms showed an
increasing trend from 1992 to 2014 (p < 0.001, Cox and Stuart
test). The proportion of non-Salmonella Enterobacteriaceae
isolated from 1992 to 2014 additionally exhibited an increasing
annual trend (p < 0.001, Cox and Stuart test) (Figure S2). No
such trend was observed for other Gram-negative organisms,
which exhibited a peak in 2007.
Time Trends of Multi-drug Resistant
Organisms
Over the study period we identified a significant increasing trend
in the proportion of MDR non-Salmonella Enterobacteriaceae
(p < 0.001; Cox and Stuart test), other Gram-negative organisms
(p = 0.006), and Gram-positive organisms (p = 0.006) isolated
(Figure 3 and Figure S3). The proportion ofMDRorganismswas
regressed on time to assess the annual increase in the proportion
of MDR organisms. We additionally assessed the presence of
breakpoints in the regression to identify any specific years that
were associated with a major change in the rate of the increase
in MDR percentage. For the non-Salmonella Enterobacteriaceae
and other Gram-negative organisms, there was no breakpoint
in the regression plots, signifying a constant increase in the
proportion of MDR organisms of 1.5 and 1.9% per year,
respectively (Figure 3). Conversely, the Gram-positive organisms
exhibited a breakpoint in 2010/2011, indicating acceleration
in the annual increase of the proportion of MDR organisms
from 2011 onwards (1992–2010: 1.26% annual increase in
the proportion of MDR organisms, 2011–2014: 7.61% annual
increase).
On investigating the time trends for MDR and non-MDR
organisms we identified three distinct periods during which:
(i) the number of isolated non-MDR organisms was greater
than the number of MDR organisms (1992–2000, MDR/non-
MDR <1), (ii) the number of isolated non-MDR organisms
and MDR organisms was approximately equal (2000–2010,
MDR/non-MDR≈1), and (iii) the number of MDR organisms
was greater than the number of non-MDR organisms (2010–
2014, MDR/non-MDR > 1) (Figure 2).
The Origins of Multi-Drug Resistant
Organisms
Over the investigative period, the majority of positive blood
cultures originated from patients attending the emergency
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FIGURE 1 | The annual distribution of the aetiological agents associated with bacteraemia. The distribution of non-Salmonella Enterobacteriaceae (A), other
Gram-negative organisms (B), and Gram-positive organisms (C) isolated from positive blood cultures in this single healthcare facility between April 1992 and
December 2014.
department (3,808/10,496; 36.3%), the pediatric ward
(2,217/10,496; 21.1%), and the outpatient department
(1,528/10,496; 14.6%). The yearly distribution of wards
from where the various groups of organisms were
isolated is shown in Figure 3. The proportion of blood
cultures positive with Enterobacteriaceae from patients
attending the emergency department (in comparison
to other wards in the hospital) showed an increasing
trend between 1992 and 2014 (p = 0.03; Cox and Stuart
test).
Finally, we assessed the relative distribution of MDR and
non-MDR organisms in different hospital wards (Figure S4).
Over the entire period, for both the MDR and the non-MDR
organisms, the majority of organisms were isolated from patients
attending the emergency department (MDR: 36.4%; 1,938/5,319,
non-MDR: 36.3%; 1,859/5,127), followed by the pediatric ward
(MDR: 22.7%; 1,206/5,319, non-MDR: 19.6%; 1,004/5,127), and
the out-patient department (MDR: 12.5%; 663/5,319, non-MDR:
16.7%; 857/5,127). The number of bacteriologically positive
cultures originating from the emergency department increased
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FIGURE 2 | Antimicrobial resistance trends from 1992 to 2014. The proportion of MDR Enterobacteriaceae non-Salmonella (A), other Gram-negative organisms (B),
and Gram-positive organisms (C) isolated between 1992 and 2014. Time trends of MDR vs. non-MDR isolates [(D) count and (E) distribution]. Linear trend lines (blue)
and 95% CI for the regression lines (shaded) are overlaid; the slopes of the regression line (with 95% CI) are indicated (A-C) two regression lines are present in (C) to
highlight the “breakpoint” in the slope.
throughout the study period. There was an increasing trend in the
proportion of MDR organisms in all bacteria-positive cultures in
the emergency ward (p= 0.006, Cox and Stuart test), the pediatric
department (p = 0.006, Cox and Stuart test), and the outpatient
department (p= 0.006, Cox and Stuart test).
DISCUSSION
In this retrospective analysis of bacteraemia from a single hospital
in Kathmandu, we report a 13.5% bacterial isolation rate from
blood cultures, which is comparable with other bacteraemia
studies from Nepal and elsewhere (5, 20–22). Similarly, the
array of isolated organisms was similar to those reported in
other studies investigating the etiology of bloodstream infections
(2, 3, 22–25), and childhood septicaemia (5, 11, 25, 26).
The most common Gram-negative, non-Salmonella organisms
to be isolated from blood cultures within this population
were Enterobacter spp., followed by Acinetobacter spp., E. coli
and Klebsiella spp., a distribution that has been observed
previously (3, 5, 23, 27). The dominance of Enterobacter spp.
in this setting was unexpected, but there have been recent
observations regarding the increasing presence of Enterobacter
spp. bacteraemia (28). This escalation is cause for concern,
as this bacterial genus presents particular challenges for the
selection of optimal antimicrobial therapy due to the presence
of chromosomally encoded AmpC beta-lactamases (25). Among
the Gram-positive organisms (excluding Coagulase negative
Staphylococci, which were reported for neonates only), S. aureus,
Non-haemolytic Streptococci and S. pneumoniae were the most
commonly isolated pathogens from blood cultures; this is also a
common array of organisms associated with bacteraemia (5, 8, 24,
29). None of these bacteria were covered by any vaccine schedule
in the country during the period of analysis.
Over the study period, there was a notable increase in
bacteraemia cases originating from the emergency department,
and a corresponding increase in the proportion of MDR
organisms originating from patients in the emergency and
outpatient departments, both of which receive patients directly
from the community. This observation suggests that community-
acquired bacteraemia caused by MDR pathogens is increasing
and becoming a major cause of hospital admissions. These data
also demonstrated a hospital-wide increase in the proportion of
MDR Enterobacteriaceae, other Gram-negative organisms, and
Gram-positive organisms isolated over the analysis period. In
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FIGURE 3 | The annual distribution of wards in which the positive blood samples originated. Plots showing the hospital wards from which the positive blood samples
originated between April 1992 and December 2014; Enterobacteriaceae non-Salmonella (A), other Gram-negative organisms (B), and Gram-positive organisms (C).
Maternity, birthing, post-partum and gynecology wards were grouped under “maternity/gynecology,” pediatric and nursery wards were grouped under “pediatric,” and
orthopedic, private, medical, and surgical wards were grouped under “other”.
fact, from 2010, MDR isolates represented more than half of
the non-Salmonella bacteria isolated from blood in this location.
These data detail a worrying increase in MDR Enterobacter spp.,
Klebsiella spp., and E. coli, circulating both within the community
and the hospital with the capacity to cause bloodstream
infections. The increasing significance of Klebsiella pneumoniae,
an organism that has already caused major outbreaks in this
hospital, raises specific concerns given its ability to be a reservoir
of AMR genes that can be transferred to other Enterobacteriaceae
(30).
The precise reason(s) for the increase in the proportion of
MDR organisms being isolated from patients in the community
is unclear; we speculate that this increase is associated with
an increasing population and ease of access to antimicrobials.
Nepal is a landlocked country located between India and
China and Kathmandu in the central valley is the capital
city. Therefore, this location naturally acts as major nucleus
within South Asia, with an elevated likelihood of antimicrobial
resistant organisms being imported from neighboring countries.
Furthermore, immigration into the capital city has increased
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dramatically over the last 25 years, both as a consequence of
the civil war (1996–2006) and economic migration from rural
areas. This increase in population has placed substantial strains
on the healthcare system and the city infrastructure, making
pathogen transmission more likely. Access to antimicrobials
in the community without prescription and the increasing
empirical use of latter generation broad spectrum antimicrobials
in healthcare facilities has potentially created an increasing
problem. This scenario has likely made Kathmandu a hub for the
circulation of MDR organisms in the community and healthcare
facilities.
The strength of this analysis is the aggregation of 23 years
of data from the same healthcare facility. These longitudinal
data provide a rare opportunity to observe and document
changes in the epidemiology and the AMR trends of organisms
associated with bacteraemia. With the exception of a recent 9-
year study of bloodstream infections in Bangladesh (21), we are
unaware of similar longitudinal data from other locations in
South Asia with such large numbers of blood cultures and MDR
time trends. However, some limitations need to be considered.
Over the prolonged period, the consistency of microbiological
testing (blood culture and antimicrobial susceptibility testing)
needs to be ensured to allow for a meaningful comparison
of trends. It is difficult, however, to wholly eliminate any
changes in microbiological practices or hospital organization
over time. For example, the sudden increase in the number
of Coagulase negative Staphylococci recorded from 2003 was
associated with the opening of the neonatal intensive care
unit. A further limitation was the absence of demographic and
clinical information in the data, thus preventing our ability to
associate a specific group of organisms or change in AMR profile
with patient demographics and/or clinical outcome. Similarly,
treatment data and information regarding antimicrobial use
prior to blood culture were not available. Lastly, as this analysis
was conducted using routine hospital data, these data may
not precisely reflect the epidemiology of bacteraemia in the
community. However, it is important to note that the majority
of positive blood cultures originated from individuals attending
hospital directly from the community. Similarly, the results of
this study are indicative of the situation in the Kathmandu Valley
and may not reflect the situation in the rest of South Asia.
Our work illustrates worrying changes in epidemiology and
AMR of bacteraemia within a healthcare facility in Kathmandu
and highlights the increasing significance of non-Salmonella
Enterobacteriaceae and Gram-positive bacteria over the last two
and a half decades. This study documents the rise of AMR and
MDR bloodstream pathogens in Nepal, demonstrating that MDR
is not only a concern for hospital-acquired infections, but is
rapidly becoming a significant problem for organisms circulating
in the community. Our study will serve as a unique reference
for improving clinical care, establishing treatment guidelines, and
gaining a better understanding of the changing epidemiology of
AMR pathogens.
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